|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
5.390 -0.010 (-0.185%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 876,535 | 5.793% | 828,541 | 899,359 | 655,825 | 737,374 |
| Cost of Sales | (97,932) | 9.126% | (89,742) | (88,897) | (69,181) | (114,680) |
| Gross Profit | 778,603 | 5.388% | 738,799 | 810,462 | 586,644 | 622,694 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (161) | -91.744% | (1,950) | (579) | 0 | 0 | |
| Profit / (Loss) before Taxation | 203,573 | 3.138% | 197,380 | 204,855 | 162,701 | 183,074 | |
| Taxation | (40,172) | 0.581% | (39,940) | (35,044) | (23,470) | (20,888) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 163,401 | 3.786% | 157,440 | 169,811 | 139,231 | 162,186 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | (2,621) | -23.138% | (3,410) | 2,406 | 1,190 | 2,251 |
| Depreciation & Amortisation | 28,457 | 7.466% | 26,480 | 31,215 | 20,495 | 16,416 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 28.820 | 3.893% | 27.740 | 29.720 | 24.210 | 28.120 |
| DPS (cts) | 7.000 | -- | 6.000 | 4.500 | 4.000 | 4.000 |
| Dividend Payout Ratio (%) | 24.289% | -- | 21.629% | 15.141% | 16.522% | 14.225% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.010 | -- | 3.551 | 3.169 | 3.036 | 2.735 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 163,401 |
| %Change | 3.786% |
| EPS / (LPS) | HKD 0.288 |
| NBV Per Share ($) | HKD 4.010 |